News

An Oklahoma judge has ruled that drug manufacturer Johnson & Johnson created a public nuisance in their deceptive marketing of opioid pain medications, helping to cause the state’s opioid crisis, and have been ordered to pay $572 million to the state.

The FDA has approved the first generic versions of Lyrica (pregabalin), granting approvals to a total of nine pharmaceutical companies for five different conditions, including the management of neuropathic pain associated with spinal cord injury.

The FDA recently advised that rare but serious injuries, including death, have happened with certain common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while not fully awake.

Sagent Pharmaceuticals, Inc. announced a nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) – an NSAID – due to a lack of sterility assurance.